Lundberg Sven Ante

DirectorQ32 Bio Inc. (QTTB) · full profile →Form 4 · filed Feb 26, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
12
0 non-derivative · 12 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 24, 2025Grant(A)13K$013K
Feb 24, 2025Grant(A)6K$06K
Feb 24, 2025Disposed to issuer(D)3K$00
Feb 24, 2025Grant(A)3K$03K
Feb 24, 2025Disposed to issuer(D)13K$00
Feb 24, 2025Grant(A)2K$02K
Feb 24, 2025Disposed to issuer(D)1K$00
Feb 24, 2025Disposed to issuer(D)6K$00
Feb 24, 2025Disposed to issuer(D)23K$00
Feb 24, 2025Grant(A)23K$023K
Feb 24, 2025Disposed to issuer(D)2K$00
Jan 15, 2025Grant(A)23K$023K

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-028243) within minutes of acceptance. Every field above traces to the original document. Verify it directly: